The Medical Advisor

Dr. Lee Cowden says most people don't die from cancer; they die from the side effects of treatment. While the "war against cancer" is moving toward more personalized and so-called "precision medicine" treatments, the old standby model of "cut, poison and burn," via surgery, chemotherapy and radiation, is still widely used and regarded as the standard of care for many cancer cases. One of the major problems with chemotherapy is its indiscriminate toxicity, which poisons your body systemically in an attempt to knock out cancer cells. There have long been signs that this model has fatal flaws and may cause more harm than good. In the case of the breast cancer chemotherapy drug Tamoxifen, for instance, patients must trade one risk for another, as while it may reduce breast cancer, it more than doubles women's risk of uterine cancer. (1) Serious, sometimes-fatal side effects (or more aptly, simply effects) of chemotherapy are common, as are serious unf...

Exploring Fenbendazole as a Potential Treatment for Stage 4 Pancreatic Cancer Pancreatic cancer is one of the most aggressive and challenging cancers to treat, especially in its advanced stages. With conventional treatments often offering limited success, many patients and researchers are exploring alternative and adjunct therapies. One such emerging option is fenbendazole , an anti-parasitic drug traditionally used in veterinary medicine, which has recently gained attention for its potential anti-cancer properties. Pancreatic Cancer Awareness In this article, we examine nine case studies of fenbendazole and its possible role in managing late stage pancreatic cancer. Could this repurposed drug offer new hope for patients seeking additional treatment options? Let’s take a closer look.   Pancreatic Cancer Success Stories Case 1:  77 year old Stage ...

There is limited publicly available, peer-reviewed evidence specifically documenting success stories of Fenbendazole and Ivermectin use in treating salivary gland cancer in humans. Both drugs, traditionally used as antiparasitics (Fenbendazole in veterinary medicine and Ivermectin in humans and animals), have gained attention for their potential anticancer properties based on preclinical studies and anecdotal reports. However, clinical data remains scarce, particularly for rare cancers like salivary gland cancer. Below, we’ll summarize the available context and relevant anecdotal evidence. Background on Salivary Gland Cancer Salivary gland cancer is a rare malignancy affecting the salivary glands (e.g., parotid, submandibular, or sublingual glands), with subtypes like adenoid cystic carcinoma and mucoepidermoid carcinoma. Standard treatments include surgery, radiation, and sometimes chemotherapy, but outcomes vary depending on stage and subtype, with advanced cases often having limite...